These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7593419)

  • 41. Local and systemic impact of transcriptional up-regulation of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue in human obesity.
    Wake DJ; Rask E; Livingstone DE; Söderberg S; Olsson T; Walker BR
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3983-8. PubMed ID: 12915696
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inactivation of glucocorticoids by 11beta-hydroxysteroid dehydrogenase enzymes increases during the meiotic maturation of porcine oocytes.
    Webb RJ; Sunak N; Wren L; Michael AE
    Reproduction; 2008 Dec; 136(6):725-32. PubMed ID: 18787080
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vivo and in vitro effects of carbenoxolone on glucocorticoid receptor binding and glucocorticoid activity.
    Soro A; Panarelli M; Holloway CD; Fraser R; Kenyon CJ
    Steroids; 1997 Apr; 62(4):388-94. PubMed ID: 9090800
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Carbenoxolone does not cause a syndrome of mineralocorticoid excess in sheep.
    Dodic M; May CN; Coghlan JP
    Steroids; 1998 Feb; 63(2):99-104. PubMed ID: 9516720
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Haemodynamic and metabolic effects of carbenoxolone in normal subjects and patients with renal impairment.
    Whitworth JA; Williamson PM; Brown MA; Edwards CR
    Clin Exp Hypertens; 1994 Jul; 16(4):431-50. PubMed ID: 7920454
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enzymes and receptors: challenges and future directions.
    Funder JW
    Steroids; 1994 Feb; 59(2):164-9. PubMed ID: 8191548
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regulation of lung inflammation by local glucocorticoid metabolism: an hypothesis.
    Schleimer RP; Kato M
    J Asthma; 1992; 29(5):303-17. PubMed ID: 1522051
    [No Abstract]   [Full Text] [Related]  

  • 48. Guardian of the gate: receptors, enzymes, and mineralocorticoid function.
    Williams GH
    J Clin Endocrinol Metab; 1992 May; 74(5):961-2. PubMed ID: 1569171
    [No Abstract]   [Full Text] [Related]  

  • 49. Increased glucocorticoid activity in men with cardiovascular risk factors.
    Walker BR; Phillips DI; Noon JP; Panarelli M; Andrew R; Edwards HV; Holton DW; Seckl JR; Webb DJ; Watt GC
    Hypertension; 1998 Apr; 31(4):891-5. PubMed ID: 9535410
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Carbohydrate metabolism in glucocorticoid excess].
    Takeda N; Kokubo Y; Sasaki A
    Nihon Rinsho; 2002 Jul; 60 Suppl 7():703-8. PubMed ID: 12238121
    [No Abstract]   [Full Text] [Related]  

  • 51. Carbenoxolone effects in congenital adrenal hyperplasia.
    Walker BR; Stewart PM
    Clin Endocrinol (Oxf); 2000 Feb; 52(2):246-8. PubMed ID: 10671957
    [No Abstract]   [Full Text] [Related]  

  • 52. Safety, tolerability, pharmacodynamics and pharmacokinetics following once-daily doses of BI 187004, an inhibitor of 11 beta-hydroxysteroid dehydrogenase-1, over 28 days in patients with type 2 diabetes mellitus and overweight or obesity.
    Bianzano S; Nordaby M; Plum-Mörschel L; Peil B; Heise T
    Diabetes Obes Metab; 2023 Mar; 25(3):832-843. PubMed ID: 36478142
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development and structure-activity relationships of tanshinones as selective 11β-hydroxysteroid dehydrogenase 1 inhibitors.
    Deng X; Huang SL; Ren J; Pan ZH; Shen Y; Zhou HF; Zuo ZL; Leng Y; Zhao QS
    Nat Prod Bioprospect; 2022 Sep; 12(1):36. PubMed ID: 36131216
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 11β-HSD1 participates in epileptogenesis and the associated cognitive impairment by inhibiting apoptosis in mice.
    Li X; Qiu W; Deng L; Lin J; Huang W; Xu Y; Zhang M; Jones NC; Lin R; Xu H; Lin L; Li P; Wang X
    J Transl Med; 2022 Sep; 20(1):406. PubMed ID: 36064418
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interaction of
    Chedid MF; do Nascimento FV; de Oliveira FS; de Souza BM; Kruel CRP; Gurski RR; Canani LH; Crispim D; Gerchman F
    Diabetol Metab Syndr; 2019; 11():78. PubMed ID: 31558916
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Application of ELISA Technique and Human Microsomes in the Search for 11
    Kupczyk D; Studzińska R; Bilski R; Woźniak A
    Biomed Res Int; 2019; 2019():5747436. PubMed ID: 31214617
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interplay between H6PDH and 11β-HSD1 implicated in the pathogenesis of type 2 diabetes mellitus.
    Yao F; Chen L; Fan Z; Teng F; Zhao Y; Guan F; Zhang M; Liu Y
    Bioorg Med Chem Lett; 2017 Sep; 27(17):4107-4113. PubMed ID: 28751144
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Investigating the role of cortisol and growth hormone in fatty liver development: fatty liver index in patients with pituitary adenomas.
    Auer MK; Stalla GK; Stieg MR
    Pituitary; 2016 Oct; 19(5):461-71. PubMed ID: 27194386
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Discovery of a novel glucose metabolism in cancer: The role of endoplasmic reticulum beyond glycolysis and pentose phosphate shunt.
    Marini C; Ravera S; Buschiazzo A; Bianchi G; Orengo AM; Bruno S; Bottoni G; Emionite L; Pastorino F; Monteverde E; Garaboldi L; Martella R; Salani B; Maggi D; Ponzoni M; Fais F; Raffaghello L; Sambuceti G
    Sci Rep; 2016 Apr; 6():25092. PubMed ID: 27121192
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tissue-specific dysregulation of cortisol regeneration by 11βHSD1 in obesity: has it promised too much?
    Stomby A; Andrew R; Walker BR; Olsson T
    Diabetologia; 2014 Jun; 57(6):1100-10. PubMed ID: 24710966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.